Menopause, complement, and hemostatic markers in women at midlife: The Study of Women's Health Across the Nation

Atherosclerosis

Volumn 231, Issue 1, 2013, Pages 54-58

  El Khoudary, Samar R ^a   Shields, Kelly J ^b   Chen, Hsiang Yu ^a   Matthews, Karen A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Coagulation; Epidemiology; Fibrinolysis; Menopause; Risk factors

Indexed keywords

BLOOD CLOTTING FACTOR 7; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SMOKING;

COAGULATION; EPIDEMIOLOGY; FIBRINOLYSIS; MENOPAUSE; RISK FACTORS;

AFRICAN AMERICANS; COMPLEMENT C3; COMPLEMENT C4; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR VII; FEMALE; FIBRINOGEN; HEMOSTASIS; HUMANS; LONGITUDINAL STUDIES; MENOPAUSE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREMENOPAUSE; TISSUE PLASMINOGEN ACTIVATOR; WOMEN'S HEALTH;

EID: 84885450500     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.08.039     Document Type: Article

References (31)

1. Lloyd-Jones D., Adams R.J., Brown T.M., et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121:e46-e215.
2. Gorodeski G.I. Impact of the menopause on the epidemiology and risk factors of coronary artery heart disease in women. Exp Gerontol 1994, 29:357-375.
3. Onat A., Uzunlar B., Hergenç G., et al. Cross-sectional study of complement C3 as a coronary risk factor among men and women. Clin Sci (Lond) 2005, 108:129-135.
4. Bhakdi S., Torzewski M., Klouche M., Hemmes M. Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol 1999, 19:2348-2354.
5. Bhakdi S., Lackner K.J., Han S.R., Torzewski M., Husmann M. Beyond cholesterol: the enigma of atherosclerosis revisited. Thromb Haemost 2004, 91:639-645.
6. Hansson G.K., Libby P., Schönbeck U., Yan Z.Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002, 91:281-291.
7. Muscari A., Bozzoli C., Gerratana C., et al. Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis 1988, 74:179-186.
8. Muscari A., Bozzoli C., Puddu G.M., et al. Association of serum C3 levels with the risk of myocardial infarction. Am J Med 1995, 98:357-364.
9. Széplaki G., Prohászka Z., Duba J., et al. Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis 2004, 177:383-389.
10. Selzer F., Sutton-Tyrrell K., Fitzgerald S., Tracy R., Kuller L., Manzi S. Vascular stiffness in women with systemic lupus erythematosus. Hypertension 2001, 37:1075-1082.
11. Speidl W.S., Kastl S.P., Huber K., Wojta J. Complement in atherosclerosis: friend or foe?. JThromb Haemost 2011, 9:428-440.
12. Niculescu F., Rus H. Complement activation and atherosclerosis. Mol Immunol 1999, 36:949-955.
13. Yasojima K., Schwab C., McGeer E.G., McGeer P.L. Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001, 21:1214-1219.
14. Hansson G.K., Holm J., Kral J.G. Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions. Acta Pathol Microbiol Immunol Scand A 1984, 92:429-435.
15. Howes J.M., Richardson V.R., Smith K.A., et al. Complement C3 is a novel plasma clot component with anti-fibrinolytic properties. Diab Vasc Dis Res 2012, 9:216-225.
16. Muscari A., Massarelli G., Bastagli L., et al. Relationship between serum C3 levels and traditional risk factors for myocardial infarction. Acta Cardiol 1998, 53:345-354.
17. Sowers M., Crawford S., Sternfed B., et al. SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition. Menopause: biology and pathology 2000, 175-188. Academic Press, New York, NY. R.A. Lobo, J. Kelsey, R. Marcus (Eds.).
18. World Health Organization Research on the menopause in the 1990s. Report of a WHO Scientific Group 1996, WHO technical report series 866, World Health Organization, Geneva, Switzerland.
19. Tepper P.G., Randolph J.F., McConnell D.S., et al. Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women's Health across the Nation (SWAN). JClin Endocrinol Metab 2012, 97:2872-2880.
20. Straub R.H. The complex role of estrogens in inflammation. Endocr Rev 2007, 28:521-574.
21. Fan J.D., Wagner B.L., McDonnell D.P. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol Endocrinol 1996, 10:1605-1616.
22. Sárvári M., Kalló I., Hrabovszky E., et al. Estradiol replacement alters expression of genes related to neurotransmission and immune surveillance in the frontal cortex of middle-aged, ovariectomized rats. Endocrinology 2010, 151:3847-3862.
23. Kósa J.P., Balla B., Kiss J., et al. Postmenopausal expression changes of immune system-related genes in human bone tissue. JClin Immunol 2009, 29:761-768.
24. Svendsen O.L., Hassager C., Christiansen C. Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism 1995, 44:369-373.
25. Toth M.J., Tchernof A., Sites C.K., Poehlman E.T. Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes Relat Metab Disord 2000, 2:226-231.
26. Lovejoy J.C., Champagne C.M., de Jonge L., Xie H., Smith S.R. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond) 2008, 32:949-958.
27. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92:347-355.
28. Hernández-Mijares A., Bañuls C., Bellod L., et al. Effect of weight loss on C3 and C4 components of complement in obese patients. Eur J Clin Invest 2012, 42:503-509.
29. Xia Z., Stanhope K.L., Digitale E., et al. Acylation-stimulating protein (ASP)/complement C3adesArg deficiency results in increased energy expenditure in mice. JBiol Chem 2004, 279:4051-4057.
30. Engström G., Hedblad B., Janzon L., Lindgärde F. Weight gain in relation to plasma levels of complement factor 3: results from a population-based cohort study. Diabetologia 2005, 48:2525-2531.
31. De Pergola G., Ciccone M.M., Guida P., et al. Relationship between C3 levels and common carotid intima-media thickness in overweight and obese patients. Obes Facts 2011, 4:159-163.